

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 8.17282730 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 8.17282730 |
| 3 | fatty acid elongation (GO:0030497) | 5.34261870 |
| 4 | myelination (GO:0042552) | 4.67822301 |
| 5 | ensheathment of neurons (GO:0007272) | 4.64025164 |
| 6 | axon ensheathment (GO:0008366) | 4.64025164 |
| 7 | regulation of meiosis I (GO:0060631) | 4.48373993 |
| 8 | DNA double-strand break processing (GO:0000729) | 4.29438338 |
| 9 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.23210220 |
| 10 | signal peptide processing (GO:0006465) | 3.96909028 |
| 11 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.92522083 |
| 12 | negative regulation of neurotransmitter transport (GO:0051589) | 3.84930324 |
| 13 | L-amino acid import (GO:0043092) | 3.81852832 |
| 14 | presynaptic membrane assembly (GO:0097105) | 3.76955709 |
| 15 | presynaptic membrane organization (GO:0097090) | 3.75183842 |
| 16 | gonadal mesoderm development (GO:0007506) | 3.67071507 |
| 17 | myelin maintenance (GO:0043217) | 3.59304934 |
| 18 | protein localization to cilium (GO:0061512) | 3.57454654 |
| 19 | oligodendrocyte differentiation (GO:0048709) | 3.46370157 |
| 20 | positive regulation of mitochondrial fission (GO:0090141) | 3.40704665 |
| 21 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.39206696 |
| 22 | photoreceptor cell differentiation (GO:0046530) | 3.39194239 |
| 23 | eye photoreceptor cell differentiation (GO:0001754) | 3.39194239 |
| 24 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.38357131 |
| 25 | glycerophospholipid catabolic process (GO:0046475) | 3.34549303 |
| 26 | piRNA metabolic process (GO:0034587) | 3.33555565 |
| 27 | response to methylmercury (GO:0051597) | 3.30513936 |
| 28 | acrosome assembly (GO:0001675) | 3.29633493 |
| 29 | positive regulation of meiosis (GO:0045836) | 3.29416195 |
| 30 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.21426831 |
| 31 | glycosphingolipid biosynthetic process (GO:0006688) | 3.20982401 |
| 32 | cullin deneddylation (GO:0010388) | 3.20765238 |
| 33 | establishment of protein localization to Golgi (GO:0072600) | 3.18485267 |
| 34 | neural tube formation (GO:0001841) | 3.17037985 |
| 35 | response to lipoprotein particle (GO:0055094) | 3.16850581 |
| 36 | single strand break repair (GO:0000012) | 3.13316575 |
| 37 | asymmetric protein localization (GO:0008105) | 3.10718104 |
| 38 | synapsis (GO:0007129) | 3.08589695 |
| 39 | photoreceptor cell maintenance (GO:0045494) | 3.08033547 |
| 40 | amino acid import (GO:0043090) | 3.07908884 |
| 41 | retinal cone cell development (GO:0046549) | 3.07838672 |
| 42 | cholesterol biosynthetic process (GO:0006695) | 3.07457454 |
| 43 | righting reflex (GO:0060013) | 3.05117915 |
| 44 | behavioral response to ethanol (GO:0048149) | 3.04786487 |
| 45 | apical protein localization (GO:0045176) | 3.02798781 |
| 46 | positive regulation of meiotic cell cycle (GO:0051446) | 2.98312437 |
| 47 | neuron cell-cell adhesion (GO:0007158) | 2.98052714 |
| 48 | protein K11-linked deubiquitination (GO:0035871) | 2.96650451 |
| 49 | intraciliary transport (GO:0042073) | 2.96624365 |
| 50 | negative regulation of DNA recombination (GO:0045910) | 2.95474643 |
| 51 | response to redox state (GO:0051775) | 2.94738345 |
| 52 | negative regulation of protein localization to cell surface (GO:2000009) | 2.92611733 |
| 53 | nucleobase catabolic process (GO:0046113) | 2.92544012 |
| 54 | protein targeting to Golgi (GO:0000042) | 2.92462880 |
| 55 | regulation of collateral sprouting (GO:0048670) | 2.91902332 |
| 56 | myelination in peripheral nervous system (GO:0022011) | 2.91483795 |
| 57 | peripheral nervous system axon ensheathment (GO:0032292) | 2.91483795 |
| 58 | negative regulation of meiosis (GO:0045835) | 2.90810376 |
| 59 | import into cell (GO:0098657) | 2.87628958 |
| 60 | Golgi to endosome transport (GO:0006895) | 2.86903636 |
| 61 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.83682026 |
| 62 | astrocyte development (GO:0014002) | 2.83579281 |
| 63 | resolution of meiotic recombination intermediates (GO:0000712) | 2.81000991 |
| 64 | mannosylation (GO:0097502) | 2.80972188 |
| 65 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.79751078 |
| 66 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.78834114 |
| 67 | C4-dicarboxylate transport (GO:0015740) | 2.77084089 |
| 68 | inositol phosphate catabolic process (GO:0071545) | 2.76130013 |
| 69 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.76003471 |
| 70 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.76003471 |
| 71 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.76003471 |
| 72 | adhesion of symbiont to host cell (GO:0044650) | 2.74225083 |
| 73 | virion attachment to host cell (GO:0019062) | 2.74225083 |
| 74 | creatine metabolic process (GO:0006600) | 2.73211669 |
| 75 | protein deneddylation (GO:0000338) | 2.72084759 |
| 76 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.70954222 |
| 77 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.70843525 |
| 78 | neuronal action potential propagation (GO:0019227) | 2.70659320 |
| 79 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.70431893 |
| 80 | anterograde synaptic vesicle transport (GO:0048490) | 2.70229314 |
| 81 | substantia nigra development (GO:0021762) | 2.69986768 |
| 82 | sterol biosynthetic process (GO:0016126) | 2.69751071 |
| 83 | germ cell migration (GO:0008354) | 2.69600516 |
| 84 | protein palmitoylation (GO:0018345) | 2.68432335 |
| 85 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.68233437 |
| 86 | male meiosis (GO:0007140) | 2.68104703 |
| 87 | establishment of mitochondrion localization (GO:0051654) | 2.67784181 |
| 88 | adult walking behavior (GO:0007628) | 2.67234957 |
| 89 | cilium morphogenesis (GO:0060271) | 2.66700839 |
| 90 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.66034234 |
| 91 | ribonucleoprotein complex disassembly (GO:0032988) | 2.65913407 |
| 92 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.64681752 |
| 93 | inositol phosphate dephosphorylation (GO:0046855) | 2.64681752 |
| 94 | neuron remodeling (GO:0016322) | 2.62125433 |
| 95 | cilium organization (GO:0044782) | 2.58229020 |
| 96 | cilium assembly (GO:0042384) | 2.58089125 |
| 97 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.56445558 |
| 98 | prenylation (GO:0097354) | 2.55988495 |
| 99 | protein prenylation (GO:0018342) | 2.55988495 |
| 100 | nonmotile primary cilium assembly (GO:0035058) | 2.55429742 |
| 101 | kynurenine metabolic process (GO:0070189) | 2.54366652 |
| 102 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.51253349 |
| 103 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.51007506 |
| 104 | membrane assembly (GO:0071709) | 2.50010186 |
| 105 | microtubule anchoring (GO:0034453) | 2.49496226 |
| 106 | acrosome reaction (GO:0007340) | 2.49090600 |
| 107 | olfactory bulb development (GO:0021772) | 2.48914914 |
| 108 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.48875048 |
| 109 | amyloid precursor protein metabolic process (GO:0042982) | 2.48329023 |
| 110 | cellular response to sterol (GO:0036315) | 2.48232063 |
| 111 | S-adenosylmethionine metabolic process (GO:0046500) | 2.48211026 |
| 112 | regulation of timing of cell differentiation (GO:0048505) | 2.47848196 |
| 113 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.47712674 |
| 114 | very long-chain fatty acid metabolic process (GO:0000038) | 2.47430512 |
| 115 | regulation of protein glycosylation (GO:0060049) | 2.46150246 |
| 116 | magnesium ion transport (GO:0015693) | 2.45744265 |
| 117 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.44871359 |
| 118 | centriole replication (GO:0007099) | 2.44212393 |
| 119 | neurotransmitter uptake (GO:0001504) | 2.44191830 |
| 120 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.44176652 |
| 121 | protein targeting to vacuole (GO:0006623) | 2.43657949 |
| 122 | protein targeting to lysosome (GO:0006622) | 2.43657949 |
| 123 | establishment of protein localization to vacuole (GO:0072666) | 2.43657949 |
| 124 | brain morphogenesis (GO:0048854) | 2.43551988 |
| 125 | regulation of glucokinase activity (GO:0033131) | 2.42371818 |
| 126 | regulation of hexokinase activity (GO:1903299) | 2.42371818 |
| 127 | isoprenoid biosynthetic process (GO:0008299) | 2.42263948 |
| 128 | positive regulation of action potential (GO:0045760) | 2.42100325 |
| 129 | postreplication repair (GO:0006301) | 2.41633191 |
| 130 | reflex (GO:0060004) | 2.41383193 |
| 131 | synaptic vesicle exocytosis (GO:0016079) | 2.41256448 |
| 132 | regulation of development, heterochronic (GO:0040034) | 2.41069215 |
| 133 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.41041316 |
| 134 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.40465668 |
| 135 | negative regulation of JUN kinase activity (GO:0043508) | 2.39490071 |
| 136 | positive regulation of growth hormone secretion (GO:0060124) | 2.38825533 |
| 137 | regulation of beta-amyloid formation (GO:1902003) | 2.38323748 |
| 138 | transmission of nerve impulse (GO:0019226) | 2.38068296 |
| 139 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.37960877 |
| 140 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.37777512 |
| 141 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.37131861 |
| 142 | response to pheromone (GO:0019236) | 2.37081125 |
| 143 | chromatin remodeling at centromere (GO:0031055) | 2.36980905 |
| 144 | glycosylceramide metabolic process (GO:0006677) | 2.36742305 |
| 145 | DNA integration (GO:0015074) | 2.35698725 |
| 146 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.35141925 |
| 147 | detection of light stimulus involved in visual perception (GO:0050908) | 2.34973004 |
| 148 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.34973004 |
| 149 | platelet dense granule organization (GO:0060155) | 2.34840385 |
| 150 | regulation of lipoprotein metabolic process (GO:0050746) | 2.34831173 |
| 151 | regulation of mitochondrial fission (GO:0090140) | 2.34687394 |
| 152 | replication fork processing (GO:0031297) | 2.33487801 |
| 153 | dopamine transport (GO:0015872) | 2.33249449 |
| 154 | axon development (GO:0061564) | 2.33244021 |
| 155 | tryptophan catabolic process (GO:0006569) | 2.33038682 |
| 156 | indole-containing compound catabolic process (GO:0042436) | 2.33038682 |
| 157 | indolalkylamine catabolic process (GO:0046218) | 2.33038682 |
| 158 | axonal fasciculation (GO:0007413) | 2.32302846 |
| 159 | CENP-A containing nucleosome assembly (GO:0034080) | 2.32047734 |
| 160 | peripheral nervous system development (GO:0007422) | 2.31157063 |
| 161 | GPI anchor metabolic process (GO:0006505) | 2.28212237 |
| 162 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.28059488 |
| 163 | gamma-aminobutyric acid transport (GO:0015812) | 2.27041626 |
| 164 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.26846703 |
| 165 | limb bud formation (GO:0060174) | 2.25970961 |
| 166 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.25559161 |
| 167 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.25559161 |
| 168 | negative regulation of axonogenesis (GO:0050771) | 2.24477379 |
| 169 | synaptic vesicle maturation (GO:0016188) | 2.23972498 |
| 170 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.23589517 |
| 171 | GPI anchor biosynthetic process (GO:0006506) | 2.21760979 |
| 172 | cerebellar granule cell differentiation (GO:0021707) | 2.20412121 |
| 173 | glycine transport (GO:0015816) | 2.17965986 |
| 174 | nerve growth factor signaling pathway (GO:0038180) | 2.17253722 |
| 175 | activated T cell proliferation (GO:0050798) | 2.13725479 |
| 176 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.13497850 |
| 177 | negative regulation of inclusion body assembly (GO:0090084) | 2.12856182 |
| 178 | negative regulation of acute inflammatory response (GO:0002674) | 2.11404333 |
| 179 | glutamate secretion (GO:0014047) | 2.09969693 |
| 180 | dopamine biosynthetic process (GO:0042416) | 2.09315519 |
| 181 | membrane raft organization (GO:0031579) | 2.08532994 |
| 182 | regulation of vacuole organization (GO:0044088) | 2.07970288 |
| 183 | glutathione biosynthetic process (GO:0006750) | 2.07473839 |
| 184 | regulation of catecholamine metabolic process (GO:0042069) | 2.07042463 |
| 185 | regulation of dopamine metabolic process (GO:0042053) | 2.07042463 |
| 186 | peptidyl-cysteine modification (GO:0018198) | 2.06453619 |
| 187 | negative regulation of synaptic transmission (GO:0050805) | 2.04355178 |
| 188 | negative regulation of exocytosis (GO:0045920) | 2.03397065 |
| 189 | acidic amino acid transport (GO:0015800) | 2.02234093 |
| 190 | cyclic nucleotide catabolic process (GO:0009214) | 2.01282755 |
| 191 | glial cell differentiation (GO:0010001) | 1.99294669 |
| 192 | positive regulation of cellular amine metabolic process (GO:0033240) | 1.99278709 |
| 193 | positive regulation of glial cell differentiation (GO:0045687) | 1.98770940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.31229125 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.53310266 |
| 3 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.52228449 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.30205293 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.27895217 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.27001037 |
| 7 | EWS_26573619_Chip-Seq_HEK293_Human | 2.26403914 |
| 8 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.14663382 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.13560208 |
| 10 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.06136870 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.06034615 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.98953716 |
| 13 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.96146296 |
| 14 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.93578719 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.92962830 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.91629879 |
| 17 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.91233238 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.90571051 |
| 19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.89165878 |
| 20 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.84674875 |
| 21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.82541998 |
| 22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.82541998 |
| 23 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.80909324 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.77980451 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.76699605 |
| 26 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.75267336 |
| 27 | VDR_22108803_ChIP-Seq_LS180_Human | 1.74300194 |
| 28 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.70628838 |
| 29 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.66937086 |
| 30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.64957348 |
| 31 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.64793029 |
| 32 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.64091119 |
| 33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.63741554 |
| 34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.63494979 |
| 35 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.63036690 |
| 36 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.62048584 |
| 37 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.62048584 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56077848 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55260343 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.52499719 |
| 41 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.51577472 |
| 42 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.48675648 |
| 43 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.48650988 |
| 44 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.48517550 |
| 45 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.48122282 |
| 46 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.45468169 |
| 47 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.43722636 |
| 48 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.42336830 |
| 49 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.41459554 |
| 50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.41346365 |
| 51 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.40821505 |
| 52 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.40301971 |
| 53 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.38558418 |
| 54 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.35946424 |
| 55 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35926204 |
| 56 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.35531981 |
| 57 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.35531981 |
| 58 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.35252345 |
| 59 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.34049624 |
| 60 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32147638 |
| 61 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.29306789 |
| 62 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28787718 |
| 63 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.28683955 |
| 64 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.28311939 |
| 65 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.27494182 |
| 66 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.26763169 |
| 67 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.25817879 |
| 68 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.24808767 |
| 69 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.23377424 |
| 70 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.23095807 |
| 71 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22470543 |
| 72 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.20627095 |
| 73 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.20432321 |
| 74 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.20124369 |
| 75 | FUS_26573619_Chip-Seq_HEK293_Human | 1.19901174 |
| 76 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.19733989 |
| 77 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.19323344 |
| 78 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.19100560 |
| 79 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.19030289 |
| 80 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.18854630 |
| 81 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.18339029 |
| 82 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.17631455 |
| 83 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.16860153 |
| 84 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16788415 |
| 85 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15655763 |
| 86 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.15064950 |
| 87 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.14827103 |
| 88 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.14559466 |
| 89 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13945092 |
| 90 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13471883 |
| 91 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.12783698 |
| 92 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.12075411 |
| 93 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.11086232 |
| 94 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11014593 |
| 95 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11014593 |
| 96 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.10938446 |
| 97 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.10930762 |
| 98 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10838407 |
| 99 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09501660 |
| 100 | JUN_21703547_ChIP-Seq_K562_Human | 1.08721518 |
| 101 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.08685665 |
| 102 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.08663298 |
| 103 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08120964 |
| 104 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.07795425 |
| 105 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.07691339 |
| 106 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07614281 |
| 107 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.07543448 |
| 108 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07186923 |
| 109 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06801327 |
| 110 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06602213 |
| 111 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.06457853 |
| 112 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.06192219 |
| 113 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05826114 |
| 114 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.05418571 |
| 115 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.05188553 |
| 116 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04832867 |
| 117 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.04566491 |
| 118 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.04418698 |
| 119 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.04294060 |
| 120 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.03978956 |
| 121 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02681556 |
| 122 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.02611375 |
| 123 | KDM2B_26808549_Chip-Seq_REH_Human | 1.01033422 |
| 124 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01023267 |
| 125 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00786701 |
| 126 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.00780256 |
| 127 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.00759464 |
| 128 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00238496 |
| 129 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00183238 |
| 130 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00027861 |
| 131 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.99889243 |
| 132 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99591764 |
| 133 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.99094405 |
| 134 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.98000805 |
| 135 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.95549288 |
| 136 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.95451620 |
| 137 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95368431 |
| 138 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.95083497 |
| 139 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.94396358 |
| 140 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92498034 |
| 141 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92280096 |
| 142 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.92005336 |
| 143 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.91518356 |
| 144 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.91518356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 4.10635014 |
| 2 | MP0003880_abnormal_central_pattern | 3.61874799 |
| 3 | MP0000569_abnormal_digit_pigmentation | 3.52059339 |
| 4 | MP0008877_abnormal_DNA_methylation | 3.33150181 |
| 5 | MP0004270_analgesia | 3.18777556 |
| 6 | MP0003690_abnormal_glial_cell | 3.11123449 |
| 7 | MP0003136_yellow_coat_color | 3.08765935 |
| 8 | MP0003950_abnormal_plasma_membrane | 3.01234758 |
| 9 | MP0002102_abnormal_ear_morphology | 2.81462759 |
| 10 | MP0008057_abnormal_DNA_replication | 2.62549603 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.35028024 |
| 12 | MP0001486_abnormal_startle_reflex | 2.33374031 |
| 13 | MP0003329_amyloid_beta_deposits | 2.28578860 |
| 14 | MP0002064_seizures | 2.24948081 |
| 15 | MP0002272_abnormal_nervous_system | 2.24910698 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.14306122 |
| 17 | MP0003634_abnormal_glial_cell | 2.13282984 |
| 18 | MP0004885_abnormal_endolymph | 2.12680849 |
| 19 | MP0001905_abnormal_dopamine_level | 2.07782527 |
| 20 | MP0005171_absent_coat_pigmentation | 2.07537377 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 2.02970036 |
| 22 | MP0009046_muscle_twitch | 2.01358639 |
| 23 | MP0003635_abnormal_synaptic_transmissio | 1.99102472 |
| 24 | MP0009745_abnormal_behavioral_response | 1.98368703 |
| 25 | MP0004742_abnormal_vestibular_system | 1.93776956 |
| 26 | MP0005187_abnormal_penis_morphology | 1.86675696 |
| 27 | MP0000778_abnormal_nervous_system | 1.78828060 |
| 28 | MP0001968_abnormal_touch/_nociception | 1.77593300 |
| 29 | MP0001529_abnormal_vocalization | 1.74843998 |
| 30 | MP0004142_abnormal_muscle_tone | 1.73372877 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.71666820 |
| 32 | MP0005423_abnormal_somatic_nervous | 1.68129930 |
| 33 | MP0002735_abnormal_chemical_nociception | 1.67012024 |
| 34 | MP0001986_abnormal_taste_sensitivity | 1.65353109 |
| 35 | MP0003633_abnormal_nervous_system | 1.64928858 |
| 36 | MP0005174_abnormal_tail_pigmentation | 1.64709212 |
| 37 | MP0002736_abnormal_nociception_after | 1.63580719 |
| 38 | MP0001188_hyperpigmentation | 1.63277785 |
| 39 | MP0000604_amyloidosis | 1.61169479 |
| 40 | MP0002063_abnormal_learning/memory/cond | 1.59332226 |
| 41 | MP0002572_abnormal_emotion/affect_behav | 1.58626804 |
| 42 | MP0001970_abnormal_pain_threshold | 1.58176275 |
| 43 | MP0002229_neurodegeneration | 1.56404020 |
| 44 | MP0003718_maternal_effect | 1.54522159 |
| 45 | MP0003787_abnormal_imprinting | 1.53447517 |
| 46 | MP0005410_abnormal_fertilization | 1.52356359 |
| 47 | MP0006054_spinal_hemorrhage | 1.51546231 |
| 48 | MP0004043_abnormal_pH_regulation | 1.46709056 |
| 49 | MP0000427_abnormal_hair_cycle | 1.46140436 |
| 50 | MP0005551_abnormal_eye_electrophysiolog | 1.43026909 |
| 51 | MP0001485_abnormal_pinna_reflex | 1.42807636 |
| 52 | MP0003631_nervous_system_phenotype | 1.42099748 |
| 53 | MP0002837_dystrophic_cardiac_calcinosis | 1.41848357 |
| 54 | MP0002067_abnormal_sensory_capabilities | 1.40653927 |
| 55 | MP0003252_abnormal_bile_duct | 1.39755517 |
| 56 | MP0004215_abnormal_myocardial_fiber | 1.37501301 |
| 57 | MP0004381_abnormal_hair_follicle | 1.36757065 |
| 58 | MP0001440_abnormal_grooming_behavior | 1.35530857 |
| 59 | MP0008260_abnormal_autophagy | 1.35278286 |
| 60 | MP0002638_abnormal_pupillary_reflex | 1.35013330 |
| 61 | MP0002733_abnormal_thermal_nociception | 1.33060362 |
| 62 | MP0008058_abnormal_DNA_repair | 1.30619752 |
| 63 | MP0005058_abnormal_lysosome_morphology | 1.30502468 |
| 64 | MP0005409_darkened_coat_color | 1.27461543 |
| 65 | MP0008789_abnormal_olfactory_epithelium | 1.27366147 |
| 66 | MP0008569_lethality_at_weaning | 1.26621060 |
| 67 | MP0000015_abnormal_ear_pigmentation | 1.23693441 |
| 68 | MP0003632_abnormal_nervous_system | 1.23203420 |
| 69 | MP0002938_white_spotting | 1.22696590 |
| 70 | MP0001501_abnormal_sleep_pattern | 1.17737094 |
| 71 | MP0001502_abnormal_circadian_rhythm | 1.17455983 |
| 72 | MP0000955_abnormal_spinal_cord | 1.16561967 |
| 73 | MP0002882_abnormal_neuron_morphology | 1.16438190 |
| 74 | MP0002928_abnormal_bile_duct | 1.16402009 |
| 75 | MP0001963_abnormal_hearing_physiology | 1.15747337 |
| 76 | MP0004924_abnormal_behavior | 1.13681984 |
| 77 | MP0005386_behavior/neurological_phenoty | 1.13681984 |
| 78 | MP0010368_abnormal_lymphatic_system | 1.11964429 |
| 79 | MP0000516_abnormal_urinary_system | 1.10928089 |
| 80 | MP0005367_renal/urinary_system_phenotyp | 1.10928089 |
| 81 | MP0002909_abnormal_adrenal_gland | 1.10533402 |
| 82 | MP0010386_abnormal_urinary_bladder | 1.09907300 |
| 83 | MP0002090_abnormal_vision | 1.09036044 |
| 84 | MP0002751_abnormal_autonomic_nervous | 1.08181474 |
| 85 | MP0002095_abnormal_skin_pigmentation | 1.07229493 |
| 86 | MP0001929_abnormal_gametogenesis | 1.07197961 |
| 87 | MP0009697_abnormal_copulation | 1.06824981 |
| 88 | MP0005084_abnormal_gallbladder_morpholo | 1.04726764 |
| 89 | MP0003195_calcinosis | 1.04174772 |
| 90 | MP0002160_abnormal_reproductive_system | 1.03364684 |
| 91 | MP0003183_abnormal_peptide_metabolism | 1.03234520 |
| 92 | MP0003121_genomic_imprinting | 1.03112412 |
| 93 | MP0003122_maternal_imprinting | 1.02911845 |
| 94 | MP0002066_abnormal_motor_capabilities/c | 1.02691733 |
| 95 | MP0005085_abnormal_gallbladder_physiolo | 1.01148392 |
| 96 | MP0010678_abnormal_skin_adnexa | 1.01066594 |
| 97 | MP0003698_abnormal_male_reproductive | 0.99797844 |
| 98 | MP0001293_anophthalmia | 0.99655655 |
| 99 | MP0001984_abnormal_olfaction | 0.99652210 |
| 100 | MP0003075_altered_response_to | 0.98899660 |
| 101 | MP0005499_abnormal_olfactory_system | 0.98814853 |
| 102 | MP0005394_taste/olfaction_phenotype | 0.98814853 |
| 103 | MP0005670_abnormal_white_adipose | 0.97929031 |
| 104 | MP0003567_abnormal_fetal_cardiomyocyte | 0.96550105 |
| 105 | MP0002233_abnormal_nose_morphology | 0.96410796 |
| 106 | MP0004134_abnormal_chest_morphology | 0.95443970 |
| 107 | MP0003890_abnormal_embryonic-extraembry | 0.95438749 |
| 108 | MP0006276_abnormal_autonomic_nervous | 0.93093308 |
| 109 | MP0002557_abnormal_social/conspecific_i | 0.92527073 |
| 110 | MP0005379_endocrine/exocrine_gland_phen | 0.92450542 |
| 111 | MP0005645_abnormal_hypothalamus_physiol | 0.91654908 |
| 112 | MP0000653_abnormal_sex_gland | 0.91361673 |
| 113 | MP0001346_abnormal_lacrimal_gland | 0.90862766 |
| 114 | MP0002234_abnormal_pharynx_morphology | 0.90475689 |
| 115 | MP0005623_abnormal_meninges_morphology | 0.90192759 |
| 116 | MP0004133_heterotaxia | 0.89500040 |
| 117 | MP0005408_hypopigmentation | 0.88310269 |
| 118 | MP0002295_abnormal_pulmonary_circulatio | 0.88083287 |
| 119 | MP0002210_abnormal_sex_determination | 0.86769971 |
| 120 | MP0002752_abnormal_somatic_nervous | 0.85943171 |
| 121 | MP0004811_abnormal_neuron_physiology | 0.85548317 |
| 122 | MP0005391_vision/eye_phenotype | 0.84691070 |
| 123 | MP0000383_abnormal_hair_follicle | 0.83743096 |
| 124 | MP0001145_abnormal_male_reproductive | 0.83433449 |
| 125 | MP0006082_CNS_inflammation | 0.82904204 |
| 126 | MP0003191_abnormal_cellular_cholesterol | 0.82833091 |
| 127 | MP0005451_abnormal_body_composition | 0.82257468 |
| 128 | MP0001299_abnormal_eye_distance/ | 0.81419495 |
| 129 | MP0005253_abnormal_eye_physiology | 0.81132116 |
| 130 | MP0003119_abnormal_digestive_system | 0.81033489 |
| 131 | MP0002184_abnormal_innervation | 0.79859824 |
| 132 | MP0001177_atelectasis | 0.79586513 |
| 133 | MP0009840_abnormal_foam_cell | 0.78523131 |
| 134 | MP0000647_abnormal_sebaceous_gland | 0.77846460 |
| 135 | MP0000462_abnormal_digestive_system | 0.76498692 |
| 136 | MP0000026_abnormal_inner_ear | 0.76379443 |
| 137 | MP0000372_irregular_coat_pigmentation | 0.75053696 |
| 138 | MP0005195_abnormal_posterior_eye | 0.75051159 |
| 139 | MP0000639_abnormal_adrenal_gland | 0.75014008 |
| 140 | MP0001851_eye_inflammation | 0.73822319 |
| 141 | MP0004858_abnormal_nervous_system | 0.73219493 |
| 142 | MP0003724_increased_susceptibility_to | 0.72073044 |
| 143 | MP0006072_abnormal_retinal_apoptosis | 0.71534178 |
| 144 | MP0009384_cardiac_valve_regurgitation | 0.70158644 |
| 145 | MP0004147_increased_porphyrin_level | 0.68739992 |
| 146 | MP0005167_abnormal_blood-brain_barrier | 0.68338322 |
| 147 | MP0002822_catalepsy | 0.66847271 |
| 148 | MP0003879_abnormal_hair_cell | 0.66606163 |
| 149 | MP0002009_preneoplasia | 0.65904976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 6.08375888 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.72269576 |
| 3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.72269576 |
| 4 | Cerebral inclusion bodies (HP:0100314) | 4.26415394 |
| 5 | Parakeratosis (HP:0001036) | 3.96598292 |
| 6 | Abnormality of the corticospinal tract (HP:0002492) | 3.63265770 |
| 7 | Supranuclear gaze palsy (HP:0000605) | 3.53799141 |
| 8 | Sensory axonal neuropathy (HP:0003390) | 3.52605047 |
| 9 | Peripheral hypomyelination (HP:0007182) | 3.44690166 |
| 10 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.40026295 |
| 11 | Onion bulb formation (HP:0003383) | 3.19134632 |
| 12 | Tubulointerstitial nephritis (HP:0001970) | 3.12595046 |
| 13 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.08325319 |
| 14 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.01896652 |
| 15 | Abnormal ciliary motility (HP:0012262) | 3.01587459 |
| 16 | Pheochromocytoma (HP:0002666) | 2.99517681 |
| 17 | Molar tooth sign on MRI (HP:0002419) | 2.97641565 |
| 18 | Abnormality of midbrain morphology (HP:0002418) | 2.97641565 |
| 19 | Pancreatic fibrosis (HP:0100732) | 2.95584204 |
| 20 | Myokymia (HP:0002411) | 2.89491683 |
| 21 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.87660100 |
| 22 | Aplasia of the phalanges of the hand (HP:0009802) | 2.87660100 |
| 23 | Aplasia involving bones of the extremities (HP:0009825) | 2.87660100 |
| 24 | Nephrogenic diabetes insipidus (HP:0009806) | 2.87230793 |
| 25 | Hyperglycinemia (HP:0002154) | 2.86827055 |
| 26 | Abolished electroretinogram (ERG) (HP:0000550) | 2.86086910 |
| 27 | Pancreatic cysts (HP:0001737) | 2.85505226 |
| 28 | Dysmetria (HP:0001310) | 2.83141803 |
| 29 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.80287660 |
| 30 | Scanning speech (HP:0002168) | 2.78432041 |
| 31 | True hermaphroditism (HP:0010459) | 2.78331504 |
| 32 | Insidious onset (HP:0003587) | 2.77548313 |
| 33 | Termporal pattern (HP:0011008) | 2.77548313 |
| 34 | Nephronophthisis (HP:0000090) | 2.77204628 |
| 35 | Intention tremor (HP:0002080) | 2.75160024 |
| 36 | Abnormal auditory evoked potentials (HP:0006958) | 2.74517352 |
| 37 | Methylmalonic acidemia (HP:0002912) | 2.65116662 |
| 38 | Focal motor seizures (HP:0011153) | 2.63848108 |
| 39 | Autoamputation (HP:0001218) | 2.63672114 |
| 40 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.63532718 |
| 41 | Clumsiness (HP:0002312) | 2.57299898 |
| 42 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.57075012 |
| 43 | Spastic gait (HP:0002064) | 2.56486430 |
| 44 | Neuroendocrine neoplasm (HP:0100634) | 2.54726627 |
| 45 | Ankle clonus (HP:0011448) | 2.54707929 |
| 46 | Absent speech (HP:0001344) | 2.54494820 |
| 47 | Progressive inability to walk (HP:0002505) | 2.53527020 |
| 48 | Retinal dysplasia (HP:0007973) | 2.48640384 |
| 49 | Abnormality of the renal medulla (HP:0100957) | 2.48439912 |
| 50 | Metabolic alkalosis (HP:0200114) | 2.47723357 |
| 51 | Abnormality of the labia minora (HP:0012880) | 2.46907097 |
| 52 | Chronic hepatic failure (HP:0100626) | 2.42992465 |
| 53 | Epileptic encephalopathy (HP:0200134) | 2.41665604 |
| 54 | Alacrima (HP:0000522) | 2.39806826 |
| 55 | Akinesia (HP:0002304) | 2.39129744 |
| 56 | Cerebral hemorrhage (HP:0001342) | 2.32883139 |
| 57 | Renal cortical cysts (HP:0000803) | 2.32134558 |
| 58 | Short tibia (HP:0005736) | 2.32060511 |
| 59 | Inability to walk (HP:0002540) | 2.31006208 |
| 60 | Megalencephaly (HP:0001355) | 2.29401599 |
| 61 | Slow saccadic eye movements (HP:0000514) | 2.28668390 |
| 62 | Thickened helices (HP:0000391) | 2.27558681 |
| 63 | Gonadotropin excess (HP:0000837) | 2.27328388 |
| 64 | Abnormal biliary tract physiology (HP:0012439) | 2.25341146 |
| 65 | Bile duct proliferation (HP:0001408) | 2.25341146 |
| 66 | Proximal tubulopathy (HP:0000114) | 2.25226540 |
| 67 | Hypokalemic alkalosis (HP:0001949) | 2.25012377 |
| 68 | Amyotrophic lateral sclerosis (HP:0007354) | 2.24589420 |
| 69 | Anteriorly placed anus (HP:0001545) | 2.24388143 |
| 70 | Increased circulating renin level (HP:0000848) | 2.24187130 |
| 71 | Absent septum pellucidum (HP:0001331) | 2.23840506 |
| 72 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.22995087 |
| 73 | Poor coordination (HP:0002370) | 2.22881354 |
| 74 | Papillary thyroid carcinoma (HP:0002895) | 2.20187347 |
| 75 | Intestinal atresia (HP:0011100) | 2.18077657 |
| 76 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.17458255 |
| 77 | Absent/shortened dynein arms (HP:0200106) | 2.17458255 |
| 78 | Action tremor (HP:0002345) | 2.16289566 |
| 79 | Vaginal atresia (HP:0000148) | 2.14435737 |
| 80 | Tubulointerstitial abnormality (HP:0001969) | 2.14058501 |
| 81 | Supernumerary spleens (HP:0009799) | 2.13668879 |
| 82 | Febrile seizures (HP:0002373) | 2.13501393 |
| 83 | Colon cancer (HP:0003003) | 2.13264345 |
| 84 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.12340354 |
| 85 | Atonic seizures (HP:0010819) | 2.12277379 |
| 86 | Hypoglycemic seizures (HP:0002173) | 2.12224561 |
| 87 | Bifid tongue (HP:0010297) | 2.12178252 |
| 88 | Abnormality of macular pigmentation (HP:0008002) | 2.12111425 |
| 89 | Axonal loss (HP:0003447) | 2.12027074 |
| 90 | Abnormality of the renal cortex (HP:0011035) | 2.11033873 |
| 91 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.10909620 |
| 92 | Lower limb muscle weakness (HP:0007340) | 2.10615629 |
| 93 | Postaxial hand polydactyly (HP:0001162) | 2.10488374 |
| 94 | Neoplasm of the adrenal cortex (HP:0100641) | 2.10122868 |
| 95 | Genital tract atresia (HP:0001827) | 2.09987407 |
| 96 | Leukodystrophy (HP:0002415) | 2.09909027 |
| 97 | Hypothermia (HP:0002045) | 2.09461990 |
| 98 | Thyroid carcinoma (HP:0002890) | 2.09393849 |
| 99 | Abnormality of vitamin B metabolism (HP:0004340) | 2.09211690 |
| 100 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.08710061 |
| 101 | Hypoglycemic coma (HP:0001325) | 2.08172994 |
| 102 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.07946693 |
| 103 | Dialeptic seizures (HP:0011146) | 2.07928883 |
| 104 | Hypoplastic pelvis (HP:0008839) | 2.07572525 |
| 105 | Medulloblastoma (HP:0002885) | 2.07384258 |
| 106 | Central scotoma (HP:0000603) | 2.06996864 |
| 107 | Specific learning disability (HP:0001328) | 2.06746408 |
| 108 | Abnormality of chromosome stability (HP:0003220) | 2.06271436 |
| 109 | Rhinitis (HP:0012384) | 2.04997891 |
| 110 | Gait imbalance (HP:0002141) | 2.04480408 |
| 111 | Glioma (HP:0009733) | 2.04237693 |
| 112 | Humeroradial synostosis (HP:0003041) | 2.03427174 |
| 113 | Synostosis involving the elbow (HP:0003938) | 2.03427174 |
| 114 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.02283039 |
| 115 | Broad-based gait (HP:0002136) | 2.02194503 |
| 116 | Methylmalonic aciduria (HP:0012120) | 2.00821986 |
| 117 | Diplopia (HP:0000651) | 1.99962564 |
| 118 | Abnormality of binocular vision (HP:0011514) | 1.99962564 |
| 119 | Hemiparesis (HP:0001269) | 1.99954432 |
| 120 | Progressive cerebellar ataxia (HP:0002073) | 1.99465597 |
| 121 | Hypomagnesemia (HP:0002917) | 1.98691739 |
| 122 | Broad foot (HP:0001769) | 1.96546100 |
| 123 | Hepatosplenomegaly (HP:0001433) | 1.96494877 |
| 124 | Spastic paraparesis (HP:0002313) | 1.95997758 |
| 125 | Hyperventilation (HP:0002883) | 1.93941234 |
| 126 | Decreased lacrimation (HP:0000633) | 1.93403242 |
| 127 | Hip dysplasia (HP:0001385) | 1.93314704 |
| 128 | Medial flaring of the eyebrow (HP:0010747) | 1.93254432 |
| 129 | Neuronal loss in central nervous system (HP:0002529) | 1.93064066 |
| 130 | Poor speech (HP:0002465) | 1.92813856 |
| 131 | Paraparesis (HP:0002385) | 1.92626269 |
| 132 | Scotoma (HP:0000575) | 1.92046931 |
| 133 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.91635286 |
| 134 | Peripheral demyelination (HP:0011096) | 1.91299198 |
| 135 | Split foot (HP:0001839) | 1.89278965 |
| 136 | Ketoacidosis (HP:0001993) | 1.88114845 |
| 137 | Premature skin wrinkling (HP:0100678) | 1.87456706 |
| 138 | Cortical dysplasia (HP:0002539) | 1.86590078 |
| 139 | Postaxial foot polydactyly (HP:0001830) | 1.86356322 |
| 140 | Sensorimotor neuropathy (HP:0007141) | 1.83943840 |
| 141 | White forelock (HP:0002211) | 1.83702483 |
| 142 | Abnormality of the fovea (HP:0000493) | 1.83364792 |
| 143 | Abnormal protein glycosylation (HP:0012346) | 1.82917362 |
| 144 | Abnormal glycosylation (HP:0012345) | 1.82917362 |
| 145 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.82917362 |
| 146 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.82917362 |
| 147 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.82257008 |
| 148 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.82257008 |
| 149 | Abnormality of glycine metabolism (HP:0010895) | 1.82211156 |
| 150 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.82211156 |
| 151 | Xerostomia (HP:0000217) | 1.81637779 |
| 152 | Truncal ataxia (HP:0002078) | 1.81321315 |
| 153 | Congenital primary aphakia (HP:0007707) | 1.80782291 |
| 154 | Focal seizures (HP:0007359) | 1.80300614 |
| 155 | Drooling (HP:0002307) | 1.79788907 |
| 156 | Cerebral hypomyelination (HP:0006808) | 1.77525656 |
| 157 | Polyphagia (HP:0002591) | 1.77414574 |
| 158 | Median cleft lip (HP:0000161) | 1.77328720 |
| 159 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.77313416 |
| 160 | Long nose (HP:0003189) | 1.76701653 |
| 161 | Blue irides (HP:0000635) | 1.76398450 |
| 162 | Congenital sensorineural hearing impairment (HP:0008527) | 1.75183875 |
| 163 | Abnormality of the septum pellucidum (HP:0007375) | 1.73887432 |
| 164 | Congenital hepatic fibrosis (HP:0002612) | 1.73712513 |
| 165 | Abnormal eating behavior (HP:0100738) | 1.73420976 |
| 166 | Fair hair (HP:0002286) | 1.73407028 |
| 167 | Gaze-evoked nystagmus (HP:0000640) | 1.73321978 |
| 168 | Progressive neurologic deterioration (HP:0002344) | 1.72774971 |
| 169 | Mutism (HP:0002300) | 1.72623388 |
| 170 | Generalized myoclonic seizures (HP:0002123) | 1.72586096 |
| 171 | Generalized tonic-clonic seizures (HP:0002069) | 1.72113319 |
| 172 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.71603458 |
| 173 | Patchy hypopigmentation of hair (HP:0011365) | 1.71349532 |
| 174 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.71228196 |
| 175 | Adrenal hypoplasia (HP:0000835) | 1.70803534 |
| 176 | Diminished movement (HP:0002374) | 1.70340598 |
| 177 | Stridor (HP:0010307) | 1.69760887 |
| 178 | Type II lissencephaly (HP:0007260) | 1.69591377 |
| 179 | Coronal craniosynostosis (HP:0004440) | 1.69516190 |
| 180 | Bowel incontinence (HP:0002607) | 1.69413280 |
| 181 | Abnormality of serum amino acid levels (HP:0003112) | 1.68283165 |
| 182 | Spastic paraplegia (HP:0001258) | 1.67743062 |
| 183 | Pachygyria (HP:0001302) | 1.66871538 |
| 184 | Narrow forehead (HP:0000341) | 1.66496779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.84539323 |
| 2 | STK39 | 4.70106584 |
| 3 | OXSR1 | 3.76917372 |
| 4 | TRIM28 | 3.49937106 |
| 5 | MAP4K2 | 3.40567924 |
| 6 | CASK | 3.03546100 |
| 7 | ACVR1B | 2.72749818 |
| 8 | PRPF4B | 2.70378232 |
| 9 | CDK19 | 2.68271886 |
| 10 | BCR | 2.30560101 |
| 11 | STK38L | 2.22979981 |
| 12 | PBK | 2.22583305 |
| 13 | ERBB3 | 2.22186204 |
| 14 | EPHB1 | 2.19630359 |
| 15 | PKN1 | 2.07235727 |
| 16 | MST4 | 2.05866434 |
| 17 | MAPKAPK5 | 2.05649809 |
| 18 | WNK4 | 1.98818675 |
| 19 | MET | 1.93006774 |
| 20 | NTRK1 | 1.88584768 |
| 21 | TNIK | 1.87861521 |
| 22 | FGFR2 | 1.84163631 |
| 23 | EPHA4 | 1.82118002 |
| 24 | EIF2AK3 | 1.79022906 |
| 25 | PINK1 | 1.66966448 |
| 26 | NEK6 | 1.65959997 |
| 27 | ZAK | 1.52147858 |
| 28 | WNK1 | 1.51540223 |
| 29 | SGK223 | 1.50144556 |
| 30 | SGK494 | 1.50144556 |
| 31 | FGR | 1.37861891 |
| 32 | MUSK | 1.32928362 |
| 33 | CSNK1G3 | 1.32872606 |
| 34 | LIMK1 | 1.32786004 |
| 35 | CSNK1A1L | 1.30898827 |
| 36 | MAP3K12 | 1.24592187 |
| 37 | MARK1 | 1.24317245 |
| 38 | PLK3 | 1.22624789 |
| 39 | BMPR1B | 1.21125552 |
| 40 | CAMK2B | 1.21081659 |
| 41 | CSNK1G2 | 1.19791841 |
| 42 | PLK4 | 1.18565476 |
| 43 | MAP3K9 | 1.16198414 |
| 44 | UHMK1 | 1.15720387 |
| 45 | GRK7 | 1.13746052 |
| 46 | PAK6 | 1.12897933 |
| 47 | STK3 | 1.09180507 |
| 48 | MAPK15 | 1.08201669 |
| 49 | AKT3 | 1.08170301 |
| 50 | ROCK2 | 1.05662382 |
| 51 | CSNK1G1 | 1.04604734 |
| 52 | INSRR | 1.04327803 |
| 53 | FER | 1.02484288 |
| 54 | MKNK2 | 1.02416776 |
| 55 | MKNK1 | 0.95604273 |
| 56 | PRKCE | 0.95326845 |
| 57 | CDK5 | 0.92746433 |
| 58 | CAMK2D | 0.92220392 |
| 59 | CAMK2A | 0.92169256 |
| 60 | GRK1 | 0.92012311 |
| 61 | MAP2K7 | 0.89105823 |
| 62 | DYRK2 | 0.85514173 |
| 63 | BMPR2 | 0.85410237 |
| 64 | ARAF | 0.85187028 |
| 65 | CLK1 | 0.84319131 |
| 66 | GRK5 | 0.83984219 |
| 67 | SRPK1 | 0.83923627 |
| 68 | PHKG1 | 0.83209441 |
| 69 | PHKG2 | 0.83209441 |
| 70 | ADRBK2 | 0.81507778 |
| 71 | NTRK3 | 0.80941655 |
| 72 | PAK3 | 0.80409553 |
| 73 | MAPK13 | 0.79247343 |
| 74 | EPHA3 | 0.79145879 |
| 75 | MAP3K13 | 0.79110490 |
| 76 | LATS1 | 0.78834733 |
| 77 | PRKCQ | 0.78381545 |
| 78 | PNCK | 0.78157103 |
| 79 | TRPM7 | 0.78125780 |
| 80 | DYRK3 | 0.77595110 |
| 81 | TIE1 | 0.77512697 |
| 82 | TTK | 0.77162336 |
| 83 | FES | 0.76825743 |
| 84 | NTRK2 | 0.74608891 |
| 85 | CAMK2G | 0.70373527 |
| 86 | TSSK6 | 0.69618760 |
| 87 | KSR2 | 0.68885971 |
| 88 | CDK14 | 0.67878333 |
| 89 | RIPK4 | 0.67172375 |
| 90 | PRKCH | 0.66979013 |
| 91 | ICK | 0.65932195 |
| 92 | CAMKK2 | 0.65588476 |
| 93 | MAP3K2 | 0.63865857 |
| 94 | MARK2 | 0.63546814 |
| 95 | EIF2AK2 | 0.61552860 |
| 96 | TAF1 | 0.61496739 |
| 97 | MAP2K4 | 0.61463561 |
| 98 | PLK1 | 0.61373460 |
| 99 | MOS | 0.61197525 |
| 100 | DAPK2 | 0.60845235 |
| 101 | PLK2 | 0.60442614 |
| 102 | MAP3K4 | 0.60430544 |
| 103 | FYN | 0.60143744 |
| 104 | NEK1 | 0.58581303 |
| 105 | PRKG1 | 0.58288997 |
| 106 | BRSK2 | 0.55775939 |
| 107 | ITK | 0.55602964 |
| 108 | MINK1 | 0.54232890 |
| 109 | YES1 | 0.53907937 |
| 110 | WEE1 | 0.52717971 |
| 111 | CDK15 | 0.51910011 |
| 112 | ERBB4 | 0.51818143 |
| 113 | PTK2B | 0.50646604 |
| 114 | CDK18 | 0.50638053 |
| 115 | PDPK1 | 0.48922922 |
| 116 | IRAK2 | 0.48900209 |
| 117 | WNK3 | 0.48031856 |
| 118 | IRAK1 | 0.47895644 |
| 119 | CDK11A | 0.47348946 |
| 120 | MAPK7 | 0.47198417 |
| 121 | TYRO3 | 0.46838323 |
| 122 | MAPK12 | 0.45625404 |
| 123 | CDK3 | 0.45200884 |
| 124 | BCKDK | 0.43014997 |
| 125 | FLT3 | 0.42654946 |
| 126 | RPS6KA4 | 0.42557197 |
| 127 | TGFBR1 | 0.42023794 |
| 128 | TEC | 0.42010616 |
| 129 | EGFR | 0.41942039 |
| 130 | PRKD1 | 0.41295279 |
| 131 | HIPK2 | 0.41043781 |
| 132 | STK24 | 0.40087998 |
| 133 | DYRK1A | 0.39527013 |
| 134 | PIK3CG | 0.39455219 |
| 135 | PRKCG | 0.39057178 |
| 136 | CSNK1A1 | 0.39036635 |
| 137 | NEK9 | 0.38570608 |
| 138 | PRKACB | 0.37386463 |
| 139 | ATM | 0.37097135 |
| 140 | NUAK1 | 0.36536711 |
| 141 | PRKACA | 0.36216721 |
| 142 | SGK1 | 0.35931529 |
| 143 | INSR | 0.35500612 |
| 144 | KSR1 | 0.35291236 |
| 145 | ADRBK1 | 0.34301704 |
| 146 | CDK6 | 0.33993098 |
| 147 | CAMK1G | 0.33433509 |
| 148 | TXK | 0.33298267 |
| 149 | VRK1 | 0.32451169 |
| 150 | CDC7 | 0.32012537 |
| 151 | STK11 | 0.30482399 |
| 152 | ABL1 | 0.29932088 |
| 153 | ATR | 0.29691940 |
| 154 | TGFBR2 | 0.28064388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.47159215 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.96814750 |
| 3 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.94247425 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.92243099 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.57527095 |
| 6 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.39789108 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.39466514 |
| 8 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.34101232 |
| 9 | Basal transcription factors_Homo sapiens_hsa03022 | 2.27670170 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.06601357 |
| 11 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.03282563 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.02170208 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.89832592 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 1.77494758 |
| 15 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.74516980 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.71375902 |
| 17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.71121075 |
| 18 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.61685535 |
| 19 | GABAergic synapse_Homo sapiens_hsa04727 | 1.57508824 |
| 20 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.57181849 |
| 21 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.56355525 |
| 22 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.49511531 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.49130118 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.46476216 |
| 25 | Nicotine addiction_Homo sapiens_hsa05033 | 1.45803947 |
| 26 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.40498337 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.38031820 |
| 28 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.37309496 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.37268801 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.36857205 |
| 31 | Morphine addiction_Homo sapiens_hsa05032 | 1.34101285 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.33582420 |
| 33 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26704390 |
| 34 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.25843179 |
| 35 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.25621750 |
| 36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.24442693 |
| 37 | Axon guidance_Homo sapiens_hsa04360 | 1.21637720 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.17737706 |
| 39 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.16434667 |
| 40 | Protein export_Homo sapiens_hsa03060 | 1.16191495 |
| 41 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.15970684 |
| 42 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.14701974 |
| 43 | Salivary secretion_Homo sapiens_hsa04970 | 1.14306508 |
| 44 | Circadian entrainment_Homo sapiens_hsa04713 | 1.13509700 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.13446982 |
| 46 | Mismatch repair_Homo sapiens_hsa03430 | 1.12278676 |
| 47 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.09829563 |
| 48 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.07550237 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 1.06043742 |
| 50 | Long-term depression_Homo sapiens_hsa04730 | 1.05685012 |
| 51 | Renin secretion_Homo sapiens_hsa04924 | 1.05228497 |
| 52 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.03581237 |
| 53 | Cocaine addiction_Homo sapiens_hsa05030 | 0.99778761 |
| 54 | RNA degradation_Homo sapiens_hsa03018 | 0.96385631 |
| 55 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.94674649 |
| 56 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.94161612 |
| 57 | Taste transduction_Homo sapiens_hsa04742 | 0.93438013 |
| 58 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.92619773 |
| 59 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.92064977 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 0.91169514 |
| 61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.89494111 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.89479957 |
| 63 | Mineral absorption_Homo sapiens_hsa04978 | 0.89470012 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.87698671 |
| 65 | Insulin secretion_Homo sapiens_hsa04911 | 0.85918720 |
| 66 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.85911662 |
| 67 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.85841435 |
| 68 | Circadian rhythm_Homo sapiens_hsa04710 | 0.84608802 |
| 69 | Alzheimers disease_Homo sapiens_hsa05010 | 0.84387708 |
| 70 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.84181223 |
| 71 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83592942 |
| 72 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.81748400 |
| 73 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.81616713 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78392335 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.77600292 |
| 76 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.77128463 |
| 77 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76716491 |
| 78 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74816621 |
| 79 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.74673087 |
| 80 | Olfactory transduction_Homo sapiens_hsa04740 | 0.73783329 |
| 81 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.72926773 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71611152 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71418302 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70835792 |
| 85 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.70529947 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69519886 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.67262129 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66792418 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.66168892 |
| 90 | Phototransduction_Homo sapiens_hsa04744 | 0.65661260 |
| 91 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65620828 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64733518 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63488763 |
| 94 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62983017 |
| 95 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.62092384 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61393535 |
| 97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.61152127 |
| 98 | Parkinsons disease_Homo sapiens_hsa05012 | 0.61028497 |
| 99 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60965838 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58271022 |
| 101 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.57847577 |
| 102 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.56761836 |
| 103 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54670349 |
| 104 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.52962294 |
| 105 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52898652 |
| 106 | ABC transporters_Homo sapiens_hsa02010 | 0.52892207 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52649867 |
| 108 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.52345877 |
| 109 | Peroxisome_Homo sapiens_hsa04146 | 0.51798336 |
| 110 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51173135 |
| 111 | Long-term potentiation_Homo sapiens_hsa04720 | 0.49189807 |
| 112 | Retinol metabolism_Homo sapiens_hsa00830 | 0.48967087 |
| 113 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.48679742 |
| 114 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48668346 |
| 115 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.48592344 |
| 116 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47908500 |
| 117 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.47624352 |
| 118 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47485304 |
| 119 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.47232979 |
| 120 | Malaria_Homo sapiens_hsa05144 | 0.45404472 |
| 121 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45032803 |
| 122 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45007205 |
| 123 | Proteasome_Homo sapiens_hsa03050 | 0.41468677 |
| 124 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.41406767 |
| 125 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41173458 |
| 126 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40761052 |
| 127 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.40460965 |
| 128 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.40377257 |
| 129 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39967248 |
| 130 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39765162 |
| 131 | Prion diseases_Homo sapiens_hsa05020 | 0.39597984 |
| 132 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.39525657 |
| 133 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39246720 |
| 134 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.38676759 |
| 135 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.36402421 |
| 136 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.35427219 |
| 137 | Cell cycle_Homo sapiens_hsa04110 | 0.33881660 |
| 138 | RNA transport_Homo sapiens_hsa03013 | 0.27943666 |
| 139 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.26948511 |
| 140 | Purine metabolism_Homo sapiens_hsa00230 | 0.23047105 |

